Pediatrix Medical Group (NYSE:MD) Stock Crosses Above Two Hundred Day Moving Average – Time to Sell?

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $14.58 and traded as high as $17.00. Pediatrix Medical Group shares last traded at $16.91, with a volume of 620,584 shares.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. Zacks Research cut shares of Pediatrix Medical Group from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 7th. UBS Group increased their price objective on shares of Pediatrix Medical Group from $16.00 to $16.50 and gave the stock a “neutral” rating in a report on Thursday, August 14th. Wall Street Zen raised shares of Pediatrix Medical Group from a “buy” rating to a “strong-buy” rating in a report on Saturday, October 4th. Leerink Partners increased their target price on shares of Pediatrix Medical Group from $14.50 to $17.00 and gave the company a “market perform” rating in a research report on Friday, September 5th. Finally, Truist Financial set a $17.00 target price on shares of Pediatrix Medical Group in a research report on Tuesday, October 14th. Two equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $16.93.

Pediatrix Medical Group Stock Up 2.8%

The stock’s 50-day moving average is $16.59 and its 200-day moving average is $14.58. The stock has a market cap of $1.47 billion, a P/E ratio of 13.10 and a beta of 1.26. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.70.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.53 earnings per share for the quarter, beating the consensus estimate of $0.42 by $0.11. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The company had revenue of $468.84 million during the quarter, compared to analyst estimates of $464.37 million. During the same quarter last year, the firm posted $0.34 EPS. The business’s revenue for the quarter was down 7.1% on a year-over-year basis. As a group, research analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Pediatrix Medical Group

Several large investors have recently made changes to their positions in MD. GAMMA Investing LLC boosted its position in shares of Pediatrix Medical Group by 219.5% during the 1st quarter. GAMMA Investing LLC now owns 2,569 shares of the company’s stock valued at $37,000 after purchasing an additional 1,765 shares in the last quarter. Marshall & Sullivan Inc. WA bought a new position in shares of Pediatrix Medical Group during the 2nd quarter valued at about $41,000. Canada Pension Plan Investment Board bought a new position in shares of Pediatrix Medical Group during the 2nd quarter valued at about $83,000. AlphaQuest LLC boosted its position in shares of Pediatrix Medical Group by 16.0% during the 1st quarter. AlphaQuest LLC now owns 5,877 shares of the company’s stock valued at $85,000 after purchasing an additional 811 shares in the last quarter. Finally, Quantbot Technologies LP bought a new position in shares of Pediatrix Medical Group during the 2nd quarter valued at about $99,000. Institutional investors own 97.71% of the company’s stock.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.